4.6 Article

Drug Discovery of New Anti-Inflammatory Compounds by Targeting Cyclooxygenases

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety

Begum Nurpelin Saglik et al.

Summary: This study focused on the design, synthesis, and evaluation of novel compounds as selective COX-2 inhibitors, which showed significant inhibition potencies against COX-2 enzyme. Molecular modelling studies helped to understand the binding properties and selectivity of these derivatives on COX-2 enzyme.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike 52 Subunit

Mahmoud Kandeel et al.

Summary: The study aimed to develop new fusion inhibitors against SARS-CoV-2, designing 12 peptides with peptide #2 demonstrating potent inhibition of SARS-CoV-2 S-mediated cell-cell fusion at 1 μM concentration. This shows promise in the development of new prophylactic and therapeutic agents against SARS-CoV-2.

BIOMOLECULES & THERAPEUTICS (2021)

Article Biochemistry & Molecular Biology

Design and synthesis of pyrimidine-5-carbonitrile hybrids as COX-2 inhibitors: Anti-inflammatory activity, ulcerogenic liability, histopathological and docking studies

Abdallah M. Alfayomy et al.

Summary: Two new series of 1,3,4-oxadiazole and coumarin derivatives based on pyrimidine-5-carbonitrile scaffold were synthesized and evaluated for their COX-1/COX-2 inhibitory activity. Some compounds showed potent COX-2 inhibition and in vivo anti-inflammatory activity, with certain derivatives displaying superior efficacy and safety profile compared to the reference drug celecoxib. Molecular docking studies indicated similar binding interactions of select compounds 10c, 10j, and 14e as selective COX-2 inhibitors, with a higher potential for accessing the selectivity side pocket.

BIOORGANIC CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents

Hoda Abolhasani et al.

Summary: The newly synthesized spiroisoxazoline derivatives showed promising selective COX-2 inhibitory activity and cytotoxicity, with compound 9f containing a 3,4-dimethoxyphenyl group demonstrating superior potency. Docking calculations revealed potential interactions with COX-2 enzyme, suggesting these compounds as potential candidates for anti-inflammatory and anticancer agents.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Green synthesis of therapeutically active 1,3,4-oxadiazoles as antioxidants, selective COX-2 inhibitors and their in silico studies

Aravind R. Nesaragi et al.

Summary: A novel and green synthetic approach was developed to produce a series of compounds with high COX-2 selectivity, which also demonstrated antioxidant activity.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)

Article Chemistry, Medicinal

Design and synthesis of new 1,4,5-trisubstituted triazole-bearing benzenesulphonamide moiety as selective COX-2 inhibitors

Mohamed S. Bekheit et al.

Summary: A new series of 1,4,5-trisubstituted triazole-bearing benzenesulphonamide compounds were designed and synthesized, showing activity as both COX-1 and COX-2 inhibitors with moderate selectivity towards COX-2. Compounds 11 and 13 exhibited the highest activity as COX-2 inhibitors, with compound 13 showing moderate selectivity towards COX-2 inhibition.

MEDICINAL CHEMISTRY RESEARCH (2021)

Article Multidisciplinary Sciences

Mycophenolate suppresses inflammation by inhibiting prostaglandin synthases: a study of molecular and experimental drug repurposing

Fahad Al-Hizab et al.

Summary: Mycophenolate mofetil has anti-inflammatory, immune-suppressing, and cyclooxygenase-inhibiting properties, with higher selectivity for cyclooxygenase-2 than cyclooxygenase-1. It can be used to treat inflammatory diseases and has the potential to be an alternative to non-steroidal anti-inflammatory drugs.
Article Chemistry, Physical

Design, synthesis of new anti-inflammatory agents with a pyrazole core: COX-1/COX-2 inhibition assays, anti-inflammatory, ulcerogenic, histopathological, molecular Modeling, and ADME studies

Khaled R. A. Abdellatif et al.

Summary: A series of novel anti-inflammatory compounds were designed, synthesized, and evaluated for their high COX-2 selectivity and anti-inflammatory activity. These compounds showed promising potential in terms of COX-2 inhibition and safety in the gastrointestinal tract.

JOURNAL OF MOLECULAR STRUCTURE (2021)

Article Pharmacology & Pharmacy

Discovery of New Potent anti-MERS CoV Fusion Inhibitors

Mahmoud Kandeel et al.

Summary: A highly potent set of peptides was designed to prevent MERS-CoV fusion through competition with HR2 at its HR1 binding site. These peptides demonstrated strong inhibition of MERS-CoV cell-cell fusion and plaque formation, with no cytotoxic effects at high concentrations, suggesting their potential as promising antiviral agents.

FRONTIERS IN PHARMACOLOGY (2021)

Article Medicine, Research & Experimental

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease

Mahmoud Kandeel et al.

LIFE SCIENCES (2020)

Article Chemistry, Applied

Bullfrog Oil Reduces the Carrageenan-induced Edema in Wistar Rats by in vitro Reduction of Inflammatory Mediators

Leonardo M. Q. Barbosa et al.

JOURNAL OF OLEO SCIENCE (2020)

Article Pharmacology & Pharmacy

Olive-Derived Hydroxytyrosol Shows Anti-inflammatory Effect without Gastric Damage in Rats

Yutaka Yonezawa et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)

Review Gastroenterology & Hepatology

Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs

Ingvar Bjarnason et al.

GASTROENTEROLOGY (2018)

Article Cell Biology

Elucidating post-translational regulation of mouse CREB3 in Neuro2a cells

Kentaro Oh-hashi et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)

Article Medicine, General & Internal

Diclofenac use and cardiovascular risks: series of nationwide cohort studies

Morten Schmidt et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Review Medicine, General & Internal

Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level

Caner Gunaydin et al.

EURASIAN JOURNAL OF MEDICINE (2018)

Review Pharmacology & Pharmacy

Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain

Sabine Groesch et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)

Review Pharmacology & Pharmacy

Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective

Carlo Patrono

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)

Article Public, Environmental & Occupational Health

Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications

Alfonso E. Bello et al.

DRUG SAFETY (2014)

Review Dermatology

Inflammation in wound repair: Molecular and cellular mechanisms

Sabine A. Eming et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)

Review Immunology

Resolution of inflammation: The beginning programs the end

CN Serhan et al.

NATURE IMMUNOLOGY (2005)

Review Pharmacology & Pharmacy

Prediction of drug solubility from structure

WL Jorgensen et al.

ADVANCED DRUG DELIVERY REVIEWS (2002)

Article Urology & Nephrology

Are selective COX-2 inhibitors nephrotoxic?

MA Perazella et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2000)